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Myoplasmic resting Ca2+ regulation by ryanodine receptors is under the
control of a novel Ca2+ -binding region of the receptor
Yanyi CHEN*1, Shenghui XUE*1, Juan ZOU*, Jose R. LOPEZ†, Jenny J. YANG*2 and Claudio F. PEREZ‡2
*Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, 50 Decatur Street, NSC 552, Atlanta, GA 30303, U.S.A.
†Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, 1089 Veterinary Medicine Drive, Davis, CA 95616, U.S.A.
‡Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, 20 Shattuck Street, Boston, MA 02115, U.S.A.
Passive SR (sarcoplasmic reticulum) Ca2 + leak through the RyR
(ryanodine receptor) plays a critical role in the mechanisms
that regulate [Ca2 + ]rest (intracellular resting myoplasmic free
Ca2 + concentration) in muscle. This process appears to be
isoform-specific as expression of either RyR1 or RyR3 confers
on myotubes different [Ca2 + ]rest. Using chimaeric RyR3–RyR1
receptors expressed in dyspedic myotubes, we show that isoform-
dependent regulation of [Ca2 + ]rest is primarily defined by a
small region of the receptor encompassing amino acids 3770–
4007 of RyR1 (amino acids 3620–3859 of RyR3) named as the
CLR (Ca2 + leak regulatory) region. [Ca2 + ]rest regulation by
the CLR region was associated with alteration of RyRs’ Ca2 + -
activation profile and changes in SR Ca2 + -leak rates. Biochemical
analysis using Tb3 + -binding assays and intrinsic tryptophan
fluorescence spectroscopy of purified CLR domains revealed that
this determinant of RyRs holds a novel Ca2 + -binding domain with
conformational properties that are distinctive to each isoform.
Our data suggest that the CLR region provides channels with
unique functional properties that modulate the rate of passive SR
Ca2 + leak and confer on RyR1 and RyR3 distinctive [Ca2 + ]rest
regulatory properties. The identification of a new Ca2 + -binding
domain of RyRs with a key modulatory role in [Ca2 + ]rest regulation
provides new insights into Ca2 + -mediated regulation of RyRs.
Key words: calcium-binding site, calcium leak, myotube, skeletal
muscle, terbium fluorescence, tryptophan fluorescence.
INTRODUCTION
[Ca2 + ]rest (intracellular resting myoplasmic free Ca2 + concen-
tration) is delicately regulated by the concerted action of
multiple Ca2 + pathways that co-ordinate Ca2 + fluxes from both
sarcolemmal membrane and intracellular Ca2 + stores [1–3]. In
skeletal muscle, Ca2 + release from intracellular Ca2 + stores
is primarily regulated by RyR1 (type 1 ryanodine receptor),
which is under the modulation of multiple endogenous protein
regulators [4–6]. A role for RyRs on regulating [Ca2 + ]rest in
skeletal muscle was first supported by our studies in dyspedic
1B5 myotubes showing that expression of either RyR1 or RyR3
resulted in significant increase in myoplasmic [Ca2 + ]rest [7]. More
recently, Eltit et al. [3] have confirmed these findings, showing
that expression of RyR1 in dyspedic primary myotubes accounted
for more than half of the total [Ca2 + ]rest measured in wild-type
cells. Furthermore, the elevation of [Ca2 + ]rest by expression of
RyR1 appears to be the combined effect of both a passive Ca2 +
leak from a ryanodine-insensitive pool of RyR1 channels (leak
channels) and an enhanced basal sarcolemmal Ca2 + influx driven
by the SR (sarcoplasmic reticulum) Ca2 + leak [3,8].
Studies in dysgenic myotubes that lack expression of the
DHPR (dihydropyridine receptor) α1S subunit suggest further
that negative regulation of RyR1 function by the DHPR also
contributes to modulating the passive Ca2 + leak responsible for
[Ca2 + ]rest [2,9]. In apparent agreement with these findings, the
expression of RyR3, which does not interact with DHPR and is
therefore not subject to its negative regulation, results in dyspedic
myotubes with [Ca2 + ]rest that are significantly higher than those
restored by the expression of RyR1 [7]. However, expression of
RyR2 in dyspedic myotubes confers [Ca2 + ]rest similar to that
of RyR1 [10] despite the fact that, like RyR3, RyR2 also lacks
negative regulation by DHPR. These results led us to hypothesize
that, in addition to ryanodine-insensitive RyRs and negative
regulation by DHPR, other channel properties, which are likely to
be unique to each isoform of RyR, also contribute to modulating
the passive SR Ca2 + leak responsible for [Ca2 + ]rest regulation.
To test this hypothesis, we took advantage of the remarkable
differences in channel function and [Ca2 + ]rest modulation
conferred by RyR1 and RyR3 [7,11–13] to identify the specific
molecular determinants within the primary sequence of RyR1 and
RyR3 that define the distinctive [Ca2 + ]rest regulatory properties
of each isoform. Using a library of chimaeric RyR3–RyR1 and
RyR1–RyR3 receptors expressed in dyspedic myotubes, we show
that the ability of the RyR1 and RyR3 to confer isoform-specific
[Ca2 + ]rest regulation can be traced to a small domain encompassing
amino acids 3770–4007 of the C-terminal region of RyR1 (amino
acids 3620–3859 of RyR3), which we referred to as the CLR
(Ca2 + leak regulatory) region. Functional and structural analyses
revealed the CLR domain contains a bona fide Ca2 + -binding
domain that modulates the Ca2 + -sensing properties of RyRs.
These data suggest that modulation of [Ca2 + ]rest by RyRs is under
the direct control of a novel cation-binding region found
within the RyRs with molecular properties unique to each isoform.
Abbreviations: [Ca2+ ]rest, intracellular resting myoplasmic free Ca2+ concentration; CLR, Ca2+ leak regulatory; DHPR, dihydropyridine receptor;
fura 2/AM, fura 2 acetoxymethyl ester; HEK, human embryonic kidney; MHS, malignant hyperthermia syndrome; RyR, ryanodine receptor; SERCA1,
sarcoplasmic/endoplasmic reticulum Ca2+ -ATPase 1; SR, sarcoplasmic reticulum.
1 These authors contributed equally to this work.
2 Correspondence may be addressed to either of these authors (email jenny@gsu.edu or cperez@zeus.bwh.harvard.edu).
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MATERIALS AND METHODS
Chimaeric RyR3–RyR1 constructs
Chimaeric RyR3–RyR1 and RyR1–RyR3 constructs were
designed and cloned as described previously [14–16]. All clones
used in the present study have been tested previously and
confirmed to express and respond to stimulation by RyR agonists
4-chloro-m-cresol and/or caffeine [14–16], thus suggesting that
they express functional channels.
Cell culture, infection and Ca2+ imaging
Primary dyspedic myotubes were differentiated in a 96-well
plate format as reported previously [15,16]. Myotubes were
infected with 2.5×104 HSV-1 (herpes simplex virus 1) virion
particles containing wild-type RyR1, wild-type RyR3 or the
chimaeric cDNAs constructs [17]. Cells were loaded with 5 μM
fura 2/AM (fura 2 acetoxymethyl ester) and imaged at 510 nm
with an intensified 10-bit digital CCD (charge-coupled device)
camera (XR-Mega-10, Stanford Photonics) using a DG4 multi-
wavelength light source as described previously [18]. SR Ca2 +
content of cultured myotubes was estimated from both peak
amplitude and the area under the curve of the Ca2 + transient
induced by 40 mM caffeine stimulation in the presence of 1 μM
thapsigargin. Fluorescent signal was captured from regions of
interest within each myotube at 10 frames/s using Piper-control
acquisition software (Stanford Photonics) and expressed as the
ratio of signal collected at alternating 340 nm/380 nm excitation
wavelength. Ca2 + -entry rates were estimated from the rate of dye
quench by Mn2 + entry in myotubes loaded with 5 μM fura 2/AM
as described previously [3,18].
[3H]Ryanodine binding assay
[3H]Ryanodine binding to crude membrane extracts (0.1 mg/ml)
was performed at equilibrium (90 min at 37 ◦C) in the
presence of 250 mM KCl, 20 mM Hepes (pH 7.4) and 5 nM
[3H]ryanodine (PerkinElmer Life Sciences) in the presence
of a cocktail of protease inhibitors (CompleteTM, EDTA-
free, Roche). Free Ca2 + concentrations were obtained by
combination of 1 mM EGTA with specific amounts of CaCl2
according to calculation with the WEBMAXC Extended
program (http://www.stanford.edu/∼cpatton/maxc.html). Non-
specific binding was determined by incubating the vesicles with
5 μM unlabelled ryanodine. Separation of bound and free ligand
was performed by rapid filtration through Whatman GF/B glass
fibre filters using a 24-well Brandel cell harvester as described
previously [13].
Resting free Ca2+ measurements
[Ca2 + ]rest were obtained by direct measurements on myotubes
differentiated in 35-mm-diameter culture dishes using double-
barrelled Ca2 + -selective microelectrodes as described previously
[7,18].
Protein expression and purification
cDNA cassettes encoding either amino acids 3770–4007 of RyR1
(CLR-1) or amino acids 3620–3859 of RyR3 (CLR-3) were
cloned into the pCold-II expression vector (TakaraTM) in-frame
downstream of a molecular tag containing a streptavidin-binding
peptide and a His6 tag. An unrelated protein domain encompassing
amino acids 1–233 of RyR1 [R1-(1–233)] containing the same
tag was also expressed and used as control protein. Clones were
expressed in Escherichia coli BL21 strain in combination with
pG-KJE8 vector (TakaraTM) encoding five molecular chaperones
to optimize protein folding. Protein expression was induced
by incubation with 0.2 mM IPTG for 6–8 h at 16 ◦C in the
presence of 1 mg/ml arabinose and 2 ng/ml tetracycline. Cells
were then disrupted by sonication in solubilization buffer (20 mM
Tris/HCl, pH 7.4, 100 mM KCl, 2 mM EDTA and 0.5% Triton
X-100, supplemented with proteinase inhibitors) and soluble
proteins were then purified using Strep-trap affinity columns
(GE Healthcare) after centrifugation at 100000 g for 90 min.
Proteins were eluted with 3 mM desthiobiotin in 10 mM Tris/HCl
(pH 7.4) and then washed/concentrated with 10 mM Tris/HCl
(pH 7.4) using filtration units with a 10 kDa molecular-mass cut-
off. The purity of the isolated protein domains was evaluated using
SDS/PAGE as described previously [4].
Intrinsic fluorescence spectroscopy and Tb3+ fluorescence
Intrinsic fluorescence spectra were recorded at room temperature
(24 ◦C) using a QM1 fluorescence spectrophotometer (PTI) with
a xenon short arc lamp. Tryptophan fluorescence spectra were
collected before and after titration with different concentrations
of CaCl2 as described previously [19]. Tb3-binding affinity of
CLR-1 and CLR-3 was obtained by Tb3 + FRET analysis as
described previously [20,21] (see the Supplementary Online Data
at http://www.biochemj.org/bj/460/bj4600261add.htm).
Circular dichroism
CD spectra were recorded in the far-UV range (190–260 nm)
on a Jasco-810 spectropolarimeter at room temperature using a
0.1-cm-pathlength quartz cuvette. The measurements of purified
CLR-1 and CLR-3 regions (12–13 μM) were made in 10 mM
Tris/HCl (pH 7.4) with either 1 mM EGTA or 0.5 mM CaCl2.
All spectra documented represent the average of at least 15
scans in which the background signal from the buffer has been
subtracted from the sample signals. Thermal denaturation curves
were obtained from changes in CD signal at 222 nm between 10 ◦C
and 90 ◦C. Measurements were performed in 10 mM Tris/HCl
(pH 7.4) with protein concentrations of 10–15 μM. Thermal
transition points were calculated by curve fitting as described
previously [20].
RESULTS
[Ca2+ ]rest level of RyR3–RyR1- and RyR1–RyR3-expressing
myotubes
To assess whether the differences in myoplasmic [Ca2 + ]rest
conferred by RyR1 and RyR3 were associated to specific
structural/functional domains of each isoform, we measured
[Ca2 + ]rest of dyspedic myotubes expressing a series of chimaeric
RyR3–RyR1 constructs spanning the entire primary sequence of
RyR1 and RyR3 (Figure 1A). All myotubes presenting [Ca2 + ]rest
greater than that of dyspedic myotubes (>50 nM) were considered
to be infected and therefore to express the receptor tested [3].
Western blot analysis of infected myotubes indicates that all
chimaeric channels tested were expressed at approximately equal
levels and showed no differences in expression of the Ca2 + -
handling proteins SERCA1 (sarcoplasmic/endoplasmic reticulum
Ca2 + -ATPase 1) and calsequestrin-1 (Supplementary Figure S1
at http://www.biochemj.org/bj/460/bj4600261add.htm).
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
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Figure 1 Identification of domains of RyRs important for [Ca2+ ]rest regulation in cultured myotubes
(A) Schematic representation of RyR3-based and RyR1-based chimaeric receptors expressed in dyspedic myotubes. Numbers indicate amino acid positions in RyR1. (B) Average [Ca2 + ]rest values
restored by expression of wild-type RyR1, wild-type RyR3 and chimaeric channels Ch2, Ch4 and Ch3. ***P < 0.001 compared with wild-type RyR3. (C) Average [Ca2 + ]rest values of dyspedic
myotubes expressing chimaeras Ch2rev, Ch4rev and Ch3rev representing the exact reverse versions of Ch2, Ch4 and Ch3 respectively. Results are means +− S.D. (n = 2–4). **P < 0.01 and
***P < 0.001 in comparison with RyR1. Values inside the bars indicate total cells analysed that presented [Ca2 + ] greater than dyspedic myotubes (>50 nM).
Figure 1(B) shows that, whereas the average [Ca2 + ]rest of
RyR1-expressing myotubes is approximately 110 nM, RyR3-
expressing myotubes had significantly higher average resting free
Ca2 + levels. Chimaeric constructs Ch4 and Ch3, containing the
central and C-terminal region of RyR1 respectively, displayed
a significant reduction in [Ca2 + ]rest when compared with wild-
type RyR3. Average [Ca2 + ]rest conferred by Ch3-expressing cells
was 158 +− 18 nM (n = 15), a concentration significantly lower
than that conferred by chimaera Ch4 [188 +− 20 nM (n = 19; P <
0.001)], but slightly higher than that observed in wild-type RyR1-
expressing cells [114 +− 7 nM (n = 49; P < 0.001)]. Consistent
with these observations, we found that the reverse chimaeric
constructs, in which the corresponding Ch4 and Ch3 regions
of RyR3 were expressed in a RyR1 background (Ch4rev and
Ch3rev), resulted in a significant increase in [Ca2 + ]rest when
expressed in dyspedic myotubes (Figures 1A and 1C). Similar
to Ch3, the Ch3rev construct had a more dramatic effect on Ca2 +
homoeostasis and induced higher [Ca2 + ]rest than the Ch4rev region
(168 +− 8 nM compared with 138 +− 5 nM for Ch3rev and Ch4rev
respectively); however, the [Ca2 + ]rest reached by Ch3rev was lower
than that observed in wild-type RyR3-expressing cells (P < 0.05).
The critical structural determinant of chimaera Ch4 was
mapped further to the smaller overlapping region between
chimaeras Ch17 and Ch21 (Figures 2A and 2B), a domain of
RyR1 previously found to play a key role in the cross-talk between
RyR1 and DHPR [15,16,22]. Subdivision of chimaera Ch3 into
three smaller chimaeric constructs showed that the determinant of
RyR1 responsible for reduced [Ca2 + ]rest regulation was confined
to a smaller domain of the C-terminal region, within amino
acids 3770–4180 of RyR1 (chimaera Ch22, Figures 2A and
2C). To demonstrate that the reduction in [Ca2 + ]rest regulation
by Ch22 was not due to a conformational change, we also
tested the reverse chimaera Ch22rev, in which the region Ch22
of RyR3 was expressed into the corresponding region of RyR1
(Figure 3A). Figure 3(B) shows that, as expected, expression of
Ch22rev in dyspedic myotubes resulted in [Ca2 + ]rest that were
significantly higher than those observed for wild-type RyR1-
expressing myotubes and much closer to those restored by
wild-type RyR3 [182 +− 8 nM (n = 10) for Ch22rev compared
with 114 +− 7 nM (n = 49) for RyR1 (P < 0.001)]. The average
[Ca2 + ]rest restored by Ch22rev, however, was still lower than those
restored by wild-type RyR3 (P < 0.01).
Further analysis narrowed down the location of the [Ca2 + ]rest
regulatory domain of region Ch22 of RyR1 to its N-terminal half
(Ch25 in Figures 3A and 3C). Dyspedic myotubes expressing
Ch25 showed an average [Ca2 + ]rest value of 133 +− 18 nM(n = 18) that was significantly lower than that observed with the
larger Ch22 region [162 +− 14 nM (n = 27; P < 0.01)]. [Ca2 + ]rest
displayed by Ch25-expressing cells was not statistically different
from those observed in wild-type RyR1-expressing myotubes
(P > 0.05; Figure 3B). Overall, these data show that region Ch25,
encompassing amino acids 3770–4007 of RyR1 (amino acids
3620–3859 of RyR3, Figure 3C), holds a structural determinant
of RyR sequence that confers the Ca2 + channel with resting Ca2 + -
regulatory properties, which are specific to each isoform. Because
of the role of this domain in modulating the rate of Ca2 + leak
through the channel (see below), for simplicity we refer to this
domain of RyRs as the CLR region.
Effect of the CLR region on RyRs Ca2+ channel function
Several groups have reported significant differences in Ca2 +
channel properties between RyR1 and RyR3 [11–13,23]. To
assess whether the effect of the CLR region of RyRs on
[Ca2 + ]rest regulation of dyspedic myotubes was associated to
alterations in channel properties, we further analysed the Ca2 + -
dependence of the chimaeric construct Ch25 using [3H]ryanodine-
binding studies. Figure 4(A) shows the average Ca2 + -dependence
of [3H]ryanodine binding to membrane fractions from HEK
(human embryonic kidney)-293 cells expressing either wild-
type channels or chimaeric construct Ch25. As reported
previously, Ca2 + -dependence profiles of wild-type RyR1 and
wild-type RyR3 indicate monophasic activation for wild-
type RyR1 [EC50 = 0.41 +− 0.18 μM (n = 6)] and a biphasic
activation profile for wild-type RyR3 [EC50(1) = 0.39 +− 0.04 μM
and EC50(2) = 35.1 +− 18 μM (n = 6)] with a plateau between 1
and 10 μM. Consistent with its predominant RyR3 background,
the Ca2 + -activation curve of chimaera Ch25 showed a biphasic
activation profile, but with a more exacerbated biphasic
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
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Figure 2 Further localization of the RyR regions responsible for [Ca2+ ]rest regulation
(A) Schematic representation of chimaeric RyR3–RyR1 receptors containing several contiguous subdomains of region Ch4 and Ch3 of RyR1 into the RyR3 background. Numbers indicate amino
acid positions in RyR1. (B and C) Average [Ca2 + ]rest of myotubes expressing the chimaeric constructs depicted in (A). ***P < 0.001 compared with Ch4 (B). **P < 0.01 and ***P < 0.001 in
comparison with Ch3 (C). Values inside the bars indicate total cells analysed. Results are means +− S.D. (n = 2–5).
Figure 3 Region Ch22 of RyR3 enhances [Ca2+ ]rest regulation by RyR1
(A) Diagram of reverse chimaera Ch22rev-expressing region Ch22 of RyR3 in a RyR1 background. Additional RyR3-based chimaeras further mapping the CLR region of RyR1 are indicated. (B)
Average [Ca2 + ]rest values of dyspedic myotubes expressing constructs depicted in (A). Results are means +− S.D. (n = 2–4). Note that region Ch22 of RyR3 confers on chimaera Ch22rev significantly
higher [Ca2 + ]rest regulatory properties than that of the wild-type RyR1 channel, which is similar to that of wild-type RyR3. Further subdivision of region Ch22 into smaller domains Ch25 and Ch26
localized the [Ca2 + ]rest regulatory region at amino acids 3770–4007 of RyR1 and amino acids 3620–3859 of RyR3 (Ch25). (C) Amino acid alignment of the CLR region from RyR1 and RyR3 using
the Clustal method. Boxed sequence indicate identical residues, and the rule indicates the amino acid position in RyR1.
Ca2 + response and a wider activation plateau (1–100 μM;
Figure 4) than wild-type RyR3 [EC50(1) = 0.36 +− 0.03 μM
and EC50(2) = 465.7 +− 120 μM (n = 4)]. [3H]Ryanodine-binding
analysis of Ca2 + inhibition revealed that Ca2 + -sensitivity
for inactivation of RyR3 was 6–7-fold lower than that
of RyR1 (IC50 = 0.44 +− 0.22 mM for RyR1 compared with
IC50 = 2.68 +− 0.77 mM for RyR3). Analysis of Ca2 + inactivation
for chimaera Ch25 showed a significantly reduced sensitivity
to Ca2 + inhibition compared with wild-type RyR1, but similar
to that of wild-type RyR3 (IC50 = 3.01 +− 0.97 mM, Figure 4B).
Comparison of the [3H]ryanodine-binding data expressed as a
fraction of the basal activity (B/Bmin) shows important differences
in channel function between wild-type RyR1 and wild-type RyR3,
with RyR3 reaching noticeably higher activation levels than
RyR1 (Figure 4C). Like RyR3, chimaera Ch25 also displays
high activation levels, suggesting that, despite changes in its
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
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Figure 4 CLR region modulates the Ca2+ -dependence function of RyRs
RyR channel function was assessed by specific [3H]ryanodine binding to crude membrane preparation from HEK-293 cells permanently transformed with wild-type RyR1, wild-type RyR3 or chimaera
Ch25. (A) Normalized Ca2 + -activation curve for RyR1 (squares), RyR3 (dark circles) and Ch25 (grey circles). RyR1 is fitted to a monophasic Hill equation, whereas RyR3 and Ch25 are fitted to
the biphasic Hill equations. (B) Normalized Ca2 + -inhibition curves for wild-type RyR1, wild-type RyR3 and Ch25 fitted to a monophasic equation. (C) Ca2 + -dependence of [3H]ryanodine binding
expressed as the fraction of Bmin showing that channel activity of chimaera Ch25 preserves the same functional profile of RyR3. Activation and inhibition profiles are the combined result of four to
six experiments performed in duplicate or triplicate from multiple HEK-293 membrane preparations. Results are means +− S.E.M. (n = 4–6).
Table 1 Curve fit statistics for [3H]ryanodine-binding analyses of Ca2+
activation
Results are means +− S.D. *P < 0.001 (one-way ANOVA with Tukey’s post-hoc analysis).
Construct EC50(1) (μM) EC50(2) (μM) n
RyR1 0.41 +− 0.18 N/A 6
RyR3 0.39 +− 0.04 35.1 +− 18* 6
Ch25 0.36 +− 0.03 465.7 +− 120* 4
Ca2 + -activating profile, chimaera Ch25 preserves most of the
channel function characteristic of RyR3. The curve fit and
statistics of Ca2 + activation and inhibition for wild-type and
chimaeric receptors are presented in Tables 1 and 2. Overall,
these data suggest that substitution of the CLR region of RyRs
results in significant changes in the Ca2 + activation properties of
the chimaeric channels.
Effect of the CLR region on myoplasmic Ca2+ fluxes
Because of the importance of Ca2 + flux equilibrium to
myoplasmic [Ca2 + ]rest regulation, we also assessed whether CLR-
mediated changes in the Ca2 + -sensing properties of RyRs had
an effect on the rate of SR Ca2 + leak or rate of sarcolemmal
Ca2 + entry in dyspedic myotubes expressing either wild-type
or Ch25 constructs. SR Ca2 + leak was estimated using the
differences in SR Ca2 + load measured by the magnitude of Ca2 +
release induced by a 40 mM caffeine challenge in the presence
of the SERCA1 pump inhibitor thapsigargin. Figure 5(A) shows
that myotubes expressing wild-type RyR1 generated caffeine-
induced Ca2 + release transients that were significantly larger
than those of myotubes expressing wild-type RyR3. Analysis of
average Ca2 + transient revealed no significant differences in peak
transient amplitude between isoforms (Figure 5B). However, the
total Ca2 + released in RyR3-expressing myotubes, which was
measured as the integral of the fluorescent signal, was found to
be significantly reduced (Figure 5C), indicating an enhanced SR
Ca2 + leak. Consistent with this smaller SR Ca2 + load, RyR3-
Table 2 Curve fit statistics for [3H]ryanodine-binding analyses of Ca2+
inhibition
Results are means +− S.D.
Construct IC50 (mM) n
RyR1 0.44 +− 0.22 4
RyR3 2.68 +− 0.77 4
Ch25 3.01 +− 0.97 5
expressing myotubes also displayed significantly higher rates
of Mn2 + quench than RyR1-expressing myotubes (Figures 5D
and 5E) revealing increased rates of sarcolemmal Ca2 + entry at
rest. By comparison, Ch25-expressing cells displayed SR Ca2 +
release at levels between RyR1 and RyR3, showing similar peak
Ca2 + transient amplitude, but with significantly increased total
Ca2 + release compared with wild-type RyR3-expressing cells
(Figures 5A–5C). Likewise, Ch25-expressing myotubes showed
rates of resting Mn2 + quench similar to those of RyR1-expressing
cells and significantly lower than those of RyR3-expressing
myotubes (Figures 5D and 5E). These data suggest that myotubes
expressing Ch25 and RyR1 present similar rates of SR Ca2 +
leak and that the differences in SR Ca2 + load observed between
Ch25 and RyR1 (Figure 5C) are likely to be the result of reduced
sensitivity to Ca2 + inhibition displayed by Ch25 (Figure 4) that
allows for a faster emptying of the Ca2 + stores than RyR1. These
findings are consistent with previous studies indicating increased
basal channel function of RyR3 [24–27] and suggest that the
insertion of the CLR region of RyR1 into the RyR3 sequence
(chimaera Ch25) results in less leaky channels.
Expression and purification of the CLR region
[3H]Ryanodine-binding studies suggest the CLR region may be
involved in Ca2 + -mediated activation of RyRs. To evaluate a direct
role of this region in modulating the Ca2 + -sensing properties of
RyRs, a fragment comprising the CLR region of RyR1 (amino
acids 3770–4007, herein CLR-1) and the corresponding fragment
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
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266 Y. Chen and others
Figure 5 Exchange of CLR regions among isoforms of RyR modulate SR Ca2+ leak and sarcolemmal Ca2+ entry
(A) Average caffeine-induced Ca2 + -release transients of fura 2-loaded dyspedic myotubes expressing wild-type RyR1, wild-type RyR3 or chimaera Ch25. S.D. of the traces has been omitted for
clarity. Average peak Ca2 + transient amplitude (B) and total Ca2 + release (C) are shown for each population of myotubes. ***P < 0.001 in comparison with wild-type RyR3. (D) Representative
traces of Mn2 + quench of fura 2 fluorescence of RyR1- and RyR3-expressing myotubes showing differences in resting sarcolemmal Ca2 + entry among isoforms. (E) Average rate of Mn2 + quench,
calculated from the slope of the fluorescent signal (broken lines), is shown for each set of constructs. Results are means +− S.E.M. for a total of nine or ten individual cultured wells (n = 3). Values in
parentheses indicate total myotubes analysed.
in RyR3 (amino acids 3620–3859, herein CLR-3), were expressed
in E. coli BL21 cells and analysed for their ability to bind Ca2 + .
In order to minimize misfolding of the protein domains, the
CLR fragments were expressed in the presence of five chaperone
proteins, to assist in protein folding, and then purified from the
soluble fraction of the cell homogenate to avoid using inclusion
bodies. All purified domains, including control region R1-(1–
233), showed approximately 95% purity and molecular masses of
approximately 30 kDa, consistent with their predicted 25–27 kDa
molecular mass (Figure 6A).
Conformational analysis of CLR domains
Far-UV CD analysis of CLR-1 and CLR-3 indicate that both
purified protein domains exhibit helical conformation (Figures 6C
and 6D). The well-folded secondary structure of these fragments
is consistent with the fact that intrinsic tryptophan fluorescence
emission of the CLR regions peak at 330 nm (see Figure 8), and
suggests that the tryptophan residues are largely buried within
this folded conformation [28]. Moreover, analysis of thermal
transition revealed important differences in thermal stability
between CLR-1 and CLR-3 (Figure 6B). CLR-1 appeared to be
more stable than CLR-3 with approximately 10 ◦C difference
in melting temperature (Tm = 61.5 +− 0.2 ◦C and 51.7 +− 0.3 ◦C
for CLR-1 and CLR-3 respectively) and a more co-operative
thermal unfolding curve than RyR3. These data are consistent
with isoform-specific differences in domain packing and suggest
that the CLR region of RyR3 displays a higher degree of molecular
flexibility than its RyR1 counterpart.
Metal-binding properties of the CLR domain
Upon addition of 0.5 mM Ca2 + , both domain fragments displayed
a small, but reproducible, decrease in mean residue ellipticity
(205–225 nm) indicating Ca2 + changes in secondary structure
(Figures 6C and 6D), therefore Ca2 + interaction with the CLR
domains. Interestingly, the effects of Ca2 + in secondary structure
of CLR-1 were significantly more pronounced than the changes
observed in CLR-3. Direct cation binding was assessed using
Tb3 + fluorescence analysis. This binding assay is commonly
used to determine Ca2 + -binding sites because Tb3 + has a similar
ionic radius and metal–co-ordination chemistry to that of Ca2 + ,
while allowing for quantitative analysis [29,30]. As shown in
Figure 7, titration of the purified CLR-1 and CLR-3 domains
with micromolar concentrations of TbCl3 resulted in a significant
increase in fluorescent signal at 545 nm when excited at 280 nm.
Both CLR domains showed monophasic binding curves with
CLR-1 displaying significantly higher binding affinity for Tb3 +
than domain CLR-3 [Kd = 0.86 +− 0.07 μM for CLR-1 compared
with 3.8 +− 0.5 μM for CLR-3 (n = 3; P < 0.001); Figures 7B and
7D and Table 2], supporting further the existence of a cation-
binding pocket with moderate affinity within the primary structure
of the CLR region of RyR1 and RyR3.
To characterize further the Ca2 + -binding properties of
the cation-binding pocket, we next analysed Ca2 + -induced
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Figure 6 Purification and conformational analysis of the CLR region of RyR1 and RyR3
(A) Coomassie Blue-stained SDS/PAGE gel loaded with 2 μg/lane CLR-1, 4 μg/lane CLR-3 and 3 μg/lane R1-(1–233) purified from E. coli BL21 cells. (B) Representative thermal stability curves
for CLR-1 and CLR-3 showing changes in CD signal at 222 nm (n = 2). (C and D) Comparison of far-UV CD spectra of purified CLR-1 (circles) and CLR-3 (squares) regions in the presence of
1 mM EGTA (unfilled symbols) indicating high α-helix content and small differences in secondary/tertiary structure between isoforms. Note the small but reproducible decrease in ellipticity of the
CD spectra in the presence of 0.5 mM Ca2 + (filled symbols).
conformational changes in the purified domains by monitoring
intrinsic tryptophan fluorescence. As shown in Figures 8(A)
and 8(C), upon titrating with increasing concentrations of Ca2 +
both domain fragments displayed a large decrease in tryptophan
fluorescence. By comparison, Ca2 + titration of a control unrelated
fragment of RyR1 [R1-(1–233)], containing amino acids 1–233
of RyR1, showed only marginal fluorescence changes upon Ca2 +
addition (Figures 8B and 8D). This region of RyR1 has been
crystallized previously and its atomic structure has confirmed the
absence of formal cation-binding sites [31]. These fluorescence
data are consistent with the Ca2 + -induced conformational changes
revealed by the CD spectroscopy assay and suggest that Ca2 +
binding detected by the tryptophan fluorescence is specific to the
CLR domains.
Unlike the Tb3 + titration assay, Ca2 + titration of tryptophan
fluorescence was better fitted to a biphasic Ca2 + -binding process
(Figures 8B and 8D). This biphasic profile was particularly
evident in CLR-3 with Ca2 + -binding affinities in the micromolar
range (Kd1 = 7.3 +− 0.3 μM and Kd2 = 18.4 +− 1.6 μM). The
biphasic binding profile of domain CLR-1 was less pronounced
with Kd1 of 11.0 +− 1.8 μM and Kd2 of 21.6 +− 2.7 μM. Whereas
average Kd1 showed a slight, but significant, difference between
CLR-1 and CLR-3, there was no difference seen in average Kd2,
suggesting that the CLR region of RyR1 and RyR3 may present
Table 3 Curve fit statistics for Tb3+ - and Ca2+ -binding analyses of purified
CLR domains
Results are means +− S.D. *P < 0.05 compared with K d2; ***P < 0.001 compared with CLR-1
(Student’s t test).
Tb3 + (μM) Ca2 + (μM)
Domain K d K d1 K d2 Hill coefficient
CLR-1 0.9 +− 0.1 11.0 +− 1.8* 21.6 +− 2.7 4.9 +− 0.5
CLR-3 3.8 +− 0.5*** 7.3 +− 0.3* 18.4 +− 1.6 6.7 +− 1.8
slightly different Ca2 + -binding properties (Table 3). The high Hill
coefficients of the CLR domains are suggestive of several ligand-
binding sites; however, other factors such as the ligand-induced
change in protein conformation may also contribute to this high
level of co-operativity [32].
DISCUSSION
In a previous study, we showed that expression of RyR1 and
RyR3 in cultured dyspedic myotubes has a dramatic effect in
the resting Ca2 + regulation where RyR3 restored myoplasmic
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Figure 7 CLR-1 and CLR-3 domains bind Tb3+ with high affinity
Representative Tb3 + fluorescence spectra of purified CLR-1 (A) and CLR-3 (C) regions showing an increase in fluorescence intensity at 545 nm upon titration with Tb3 + (excitation at 280 nm).
Tb3 + binding to CLR-1 (B) and CLR-3 (D) domains is expressed as the average change in relative fluorescence intensity ([F i−F min]/[F max−F min]). Data were fitted to monophasic binding curves
using eqn (S3) (see the Supplementary Online Data at http://www.biochemj.org/bj/460/bj4600261add.htm). Results are means +− S.D. (n = 3).
[Ca2 + ]rest to significantly higher Ca2 + levels than RyR1 [7]. In
the present study, we used a series of chimaeric RyR channels
spanning the entire sequence of RyR1 and RyR3 in order to
localize and characterize the molecular determinant of each
isoform responsible for their differential effect on [Ca2 + ]rest.
Location of the resting Ca2+ -regulatory domain of RyRs
We found that the ability of RyR1 and RyR3 to differentially
modulate [Ca2 + ]rest can be traced to two regions of the primary
sequence: one is the overlapping region between chimaeras Ch17
and Ch21 (17/21, amino acids 1924–2217 of RyR1 and 1798–
2082 of RyR3) and the other the CLR region encompassing
amino acids 3770–4007 of RyR1 (amino acids 3620–3859 of
RyR3). The impact of region 17/21 on [Ca2 + ]rest regulation was
shown to be less dramatic than that of the CLR region in both
the RyR3-based (Ch4) and the RyR1-based (Ch4rev) chimaeric
constructs. Our previous studies of these chimaeric receptors
have shown that the RyR1 region encompassing region 17/21 is
directly involved in the cross-talk between DHPR and RyR1, and
confers RyR3 with the ability to restore DHPR tetrad formation,
DHPR retrograde signalling and excitation–contraction coupling
[15,16,22]. Therefore it is likely that the mild reduction in
[Ca2 + ]rest observed in dyspedic myotubes expressing Ch4, Ch21
or Ch17 could be related to an enhanced orthograde regulation by
DHPR that inhibited RyR1 function, thereby restricting overall
SR Ca2 + -leak, similar to the mechanism described by Eltit et al.
[2,3]. Nonetheless, an effect of altered Ca2 + regulation by Ch4,
Ch21 and Ch17 on the rates of SR Ca2 + leak and its subsequent
effect on [Ca2 + ]rest should not be ruled out as all these chimaeric
constructs have shown to affect both Ca2 + -activation and Ca2 + -
inhibition profiles of the channel [13].
The CLR regions of RyR1 and RyR3 were shown to have
a more dramatic effect on Ca2 + homoeostasis conferring on
chimaeric receptors [Ca2 + ]rest-regulatory properties distinctive of
the specific CLR sequence being expressed, regardless of the
overall amino acid background. In contrast with region 17/21, it
is unlikely that the effect the CLR region has on [Ca2 + ]rest could be
related to orthograde regulation by DHPR, as cumulative evidence
indicates that the C-terminal region of RyR1 is not involved
in cross-talk with the DHPR complex. Our previous studies
involving several chimaeric RyR3–RyR1 channels, including
Ch25 used in the present study, have shown that exchange of
various RyR domains containing the CLR region had a negligible
effect on either excitation–contraction coupling [14] or DHPR
Ca2 + current densities [15,16,22], suggesting that the RyR region
encompassing the CLR region is not involved directly in the
DHPR–RyR interaction.
Importantly, and consistent with our previous studies in
wild-type RyR3 and wild-type RyR1 [7], Western blot
analysis indicates that all chimaeric constructs displayed similar
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Figure 8 Characterization of the Ca2+ -binding properties of CLR-1 and CLR-3
Representative fluorescence emission spectra showing a Ca2 + -induced decrease in intrinsic tryptophan fluorescence intensity of CLR-1 (A) and CLR-3 (C) domains excited at 280 nm (filled circles).
Ca2 + titration curves were fitted to a biphasic binding process using eqns (S1) and (S2) (see the Supplementary Online Data at http://www.biochemj.org/bj/460/bj4600261add.htm) (B and D).
Results are mean +− S.D. relative fluorescence intensity (n = 3). Ca2 + -induced changes in relative fluorescence intensity of control protein R1-(1–233) (B and D, unfilled circles) are shown as
fractions of the maximal response of either CLR-1 or CLR-3.
expression levels when transfected in dyspedic myotubes.
Therefore changes in [Ca2 + ]rest like the one caused by exchange
of the CLR region could not be explained simply by changes in
expression levels of the chimaeric channels.
Chronically elevated [Ca2 + ]rest is a common feature of
skeletal muscle cells expressing RyR1 mutations linked to
MHS (malignant hyperthermia syndrome). Extensive functional
analysis of muscle cells expressing numerous MHS-linked
mutations of RyR1 has revealed that elevated [Ca2 + ]rest is often
associated with alteration of Ca2 + and Mg2 + regulation of RyR1
[3,8,33–38], with a number of these mutations being confirmed
to result in increased basal Ca2 + channel function that leads
to enhanced passive SR Ca2 + leak [8,34,36,39]. The reverse
mechanism seems to operate in chimaera Ch25 where the insertion
of the more stable CLR region of RyR1 into the RyR3 sequence
appeared to attenuate the enhanced basal channel function of
RyR3, causing myotubes to decrease both overall SR Ca2 + leak
and sarcolemmal Ca2 + entry, resulting in a subsequent reduction
of [Ca2 + ]rest. These results are also in agreement with the cell
boundary theorem that predicts permanent changes in cytosolic
Ca2 + concentration as a result of steady changes of sarcolemmal
Ca2 + fluxes [1].
Molecular properties of the CLR region
The identification of bona fide Ca2 + -binding sites in the CLR
region of RyR1 and RyR3 with Ca2 + affinities within the
physiological range seems in agreement with a role for the CLR
region in Ca2 + -mediated regulation of RyRs. However, whether
Ca2 + binding to the CLR region is involved directly in Ca2 + -
mediated activation of RyRs needs further study. Our in vitro
biochemical characterization (Ca2 + titration) of the isolated CLR
domains suggests that Ca2 + -binding affinities of CLR-1 and CLR-
3 are similar. It therefore seems unlikely that the shift of Ca2 + -
sensing properties resulting from the exchange of CLR region
in chimaera Ch25 could be explain by the overall Ca2 + -binding
properties of the CLR region alone. Instead, our conformational
analysis suggests significant differences in overall molecular
conformation between the CLR regions of RyR1 and RyR3.
Differences in the secondary/tertiary structure between CLR-1
and CLR-3 are supported by CD analysis, which revealed slight
differences in helical content among domains (Figures 6C and
6D). This difference in folded conformation is also evident from
the differential effect of Ca2 + in the CD spectra. Indeed, whereas
Ca2 + addition resulted in changes in the overall conformation
of CLR-1, it had significantly less effect on the folded structure
of CLR-3. This is supported further by thermal transition studies
(Figure 6B) that revealed important differences in thermal stability
and unfolding co-operativity between CLR domains, with the
overall structure of CLR-3 being less stable and packed than that
of CLR-1.
An intriguing result was the differences in binding profile
(monophasic compared with biphasic) and affinity of the cation-
binding pocket detected by Tb3 + - and Ca2 + -binding assays. These
differences probably arise from the intrinsic differences in which
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each assay reads out cation–protein interaction. Whereas changes
in tryptophan fluorescence are the result of global conformational
changes of the CLR domain, the Tb3 + fluorescence signal is the
result of energy transfer between nearby tryptophan residues and
Tb3 + , and therefore primarily reflects local events that are highly
sensitive to molecular distance. A monophasic binding profile
like the one observed during Tb3 + titration could stem from the
fact that tryptophan residues were present in close proximity to
only one of the Tb3 + -binding sites. This seems consistent with the
actual location of the two tryptophan residues of the CLR region,
which are found close to each other and clustered towards the
C-terminal end of the domain (Figure 3C).
At the functional level, biphasic Ca2 + -activating profiles like
the one observed in our [3H]ryanodine-binding studies have been
reported previously in RyR3 [13] and RyR2 [40,41] and are
consistent with our hypothesis that activation of RyRs may involve
at least two moderately co-operative Ca2 + -activation sites [13].
The binding of Ca2 + to multiple sites in a highly co-operative
manner have been shown to facilitate protein responses to small
changes in Ca2 + concentration [42,43]. The high degree of co-
operativity to Ca2 + -binding showed by the CLR domains (Table 3)
and the effects of these domains in the Ca2 + -activation profile
of chimaeric receptors are consistent with this idea. These data
suggest that Ca2 + -dependent activation of RyR channels may
be a complex event possibly involving multiple Ca2 + -binding
sites.
It is worth noting that the RyR1 sequence around the CLR
has been previously associated with Ca2 + regulation with
several potential Ca2 + -binding and/or Ca2 + -regulatory sites
being reported in a number of studies (Supplementary Figure
S2 at http://www.biochemj.org/bj/460/bj4600261add.htm). Even
though the nature of the Ca2 + -binding sites at the CLR region
is currently unknown, it appears that the amino acid ligands that
conform the Ca2 + -binding domain(s), do not group as continuous
canonical EF-hand motif, but rather as a discontinuous array. This
is not surprising as an analysis of the atomic structure of more than
1600 Ca2 + -binding domains have shown that discontinuous non-
EF-hand binding sites account for more than 90% of the known
structures [44]. To our knowledge, this is the first report linking
amino acids 3770–4007 of RyR1 (3620–3859 of RyR3) to either
direct Ca2 + -binding or [Ca2 + ]rest regulation. Previous studies have
associated this same region with interaction to S100A1 [45], a
Ca2 + -binding protein known to modulate Ca2 + cycling in skeletal
muscle through its interaction with the calmodulin-binding site
of RyR1 [46,47]. However, it is unlikely that the effects of the
CLR region in [Ca2 + ]rest regulation observed in our study could be
linked to binding of S100A1 because S100A1-null muscle fibres
appear to present normal [Ca2 + ]rest regulation [46].
Overall, our data revealed that the region of amino acids 3770–
4007 of RyR1 (amino acids 3620–3859 of RyR3) encompasses
a novel Ca2 + -binding domain that provide RyR with unique
conformational properties that define their distinctive modulatory
role in [Ca2 + ]rest regulation. Because this modulatory role appears
to be linked directly to the ability of RyRs to regulate passive
SR Ca2 + leak [2,3], it is conceivable that the effect of the
CLR region on [Ca2 + ]rest could result from changes in RyR
susceptibility to adopt the leak conformation. Our data, however,
do not rule out the possibility that changes in gating properties of
the functional pool of RyRs could also contribute to modulate
the overall SR Ca2 + content that drives sarcolemmal Ca2 +
fluxes and thereby [Ca2 + ]rest regulation. Lastly, the identification
of this new Ca2 + -binding domain in RyRs, which was found
to play a key role in modulating myoplasmic [Ca2 + ]rest,
provides new insights into Ca2 + -mediated regulation of RyRs
function.
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SUPPLEMENTARY METHODS
Tryptophan and Tb3+ fluorescence spectroscopy
Ca2 + -induced fluorescence changes of CLR-1 or CLR-3 (2 μM)
were monitored in the presence of 10 mM Pipes (pH 6.8) and
100 mM KCl. All solutions were dialysed against Chelex-100 for
at least 24 h to remove contaminant cations. Intrinsic tryptophan
fluorescence was monitored using excitation at 280 nm and
emission between 300 and 400 nm with 2–4-nm band passes.
Ca2 + dissociation constants of the CLR domains were calculated
separately for each binding phase. The first binding phase was
fitted to eqn (S1):
f = ([P]T + [M]T +Kd1) −
√
([P]T + [M]T +Kd1)2 − 4 [P]T [M]T
2 [P]T
(S1)
where f is the fractional change, Kd1 is the dissociation constant,
and [P]T and [M]T are the total concentration of protein and Ca2 +
respectively. The second co-operative Ca2 + -binding phase was
fitted to eqn (S2):
S = S1 + S2 [M]
h
K hd2 + [M]h
(S2)
where S is the total fluorescence signal change, S1 and
S2 are the signal changes in the first and second binding
phases respectively, [M] is the Ca2 + concentration, h is the Hill
coefficient, and Kd2 is the Ca2 + dissociation constant for the
second binding phase.
Tb3 + -binding affinity of CLR-1 and CLR-3 was obtained by
Tb3 + FRET analysis as described previously [1,2]. Briefly, 2 μM
purified CLR-1 or CLR-3 was resuspended in binding solution
(10 mM Pipes, pH 6.8, and 100 mM KCl) and titrated with
increasing concentrations of TbCl3. FRET was then acquired by
excitation of tryptophan (donor) at 280 nm and collection of Tb3 +
fluorescence emission (acceptor) between 500 and 600 nm using
a glass filter to cut off emission below 400 nm. Specific changes in
Tb3 + fluorescent signal were obtained from the emission intensity
at 545 nm after removal of free Tb3 + background signal. The Tb3 +
dissociation constant for CLR-1 or CLR-3 was obtained by fitting
the normalized fluorescent intensity data to eqn (S3):
f = ([P]T + [M]T + Kd) −
√
([P]T + [M]T + Kd)2 − 4 [P]T [M]T
2 [P]T
(S3)
where f is the fractional change, Kd is the dissociation constant,
and [P]T and [M]T are the total concentration of protein and Tb3 +
respectively.
Cell membrane isolation and immunoblotting
Crude membrane preparations were made from three 10-cm-
diameter plates of 5-day differentiated dyspedic myotubes 36 h
after infection with (1.5–2) × 106 virion particles. Myotubes
were harvested in PBS and centrifuged at 250 g for 10 min.
Cell pellets were resuspended in buffer consisting of 250 mM
sucrose and 10 mM Hepes (pH 7.4), supplemented with 1 mM
EDTA, 10 μg/ml leupeptin, 0.7 μg/ml pepstatin A, 5 μg/ml
aprotinin and 0.1 mM Pefabloc SC and then homogenized using a
Tissue-TearorTM cell disrupter (Biospect Products). Whole-cell
homogenates were centrifuged at 1500 g for 20 min and the
supernatants then collected and recentrifuged at 100000 g for
60 min at 4 ◦C. Membrane pellets were finally resuspended in
250 mM sucrose and 20 mM Hepes (pH 7.4), quick frozen in
liquid N2 and stored at − 80 ◦C. Proteins (25–30 μg/lane) were
separated in discontinuous SDS/PAGE 7–12% or 7–15% gels
[3,4] and then electroblotted on to PVDF membranes for 90 min
at 50 V. Membrane sections containing the protein to be tested
were then excised and immunoblotted separately with monoclonal
antibody 34C (J. Airey and J. Sutko, DSHB (Developmental
Study Hybridoma Bank), University of Iowa, Iowa City, IA,
U.S.A.), which recognizes both RyR1 and RyR3, monoclonal
anti-calsequestrin-1 (MA3-913, Thermo Scientific), monoclonal
anti-SERCA1 (MA3-911,Thermo Scientific) or polyclonal anti-
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (FL-335
from Santa Cruz Biotechnology) antibodies. Membranes were
then incubated with either goat anti-mouse or goat anti-
rabbit horseradish-peroxidase-conjugated secondary antibody
and developed with SuperSignal ultra chemiluminescent substrate
(Pierce) and the intensity of the signal was collected using
a Kodak Imaging Station 4000MM PRO (Carestream Health).
Band densitometry of the identified proteins was performed using
Kodak MI Software (version 4.5.1 ES). For each blot net band
intensities were normalized to GAPDH expression to correct for
protein loading and expressed as the fraction of the corresponding
band of RyR1-expressing myotubes.
Data analysis
Statistical differences among datasets were evaluated using one-
way Kruskal–Wallace ANOVA (non-parametric) analysis using
Prism 5.0 (GraphPad Software). Unless indicated otherwise,
results are means +− S.D.
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Figure S1 Relative expression of chimaeric RyRs in dyspedic myotubes
(A) Western blot analysis of crude membrane homogenates showing relative expression levels of RyRs, SERCA1 and calsequestrin-1 (Csq-1) of dyspedic myotubes infected with the wild-type or
chimaeric constructs shown in Figure 1(A) of the main text. For each immunoblot, representative results of two different membrane homogenates are shown to highlight intrinsic variability between
preparations. (B) Mean +− S.D. band intensity for each protein expressed as a fraction of the RyR1-expressing lane (broken line) for four to five blots from two separated membrane preparations.
ANOVA one-way analysis of variance (Tukey’s multiple comparison test) detected not statistically significant differences in band intensity among the different constructs.
Figure S2 Localization of Ca2+ -binding/regulatory regions of RyR1
Mapping of the CLR-1 region within the context of the C-terminal tail of RyR1. Boxes represent the location of various domains of RyR1 reported to be involved in Ca2 + -binding or Ca2 + -mediated
regulation. The location of CLR-1 does not appear to coincide with any of the prospective Ca2 + -binding regions currently identified in RyR1.
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